BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33235148)

  • 1. MEF2D-BCL9 B-Lymphoblastic Leukemia Blast Morphology Does Not Always Mimic Mature B-Cell Leukemia.
    Baek HJ; Choi YJ; Kim BR; Lee JH; Shin MG; Kook H
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):112-113. PubMed ID: 33235148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
    Suzuki K; Okuno Y; Kawashima N; Muramatsu H; Okuno T; Wang X; Kataoka S; Sekiya Y; Hamada M; Murakami N; Kojima D; Narita K; Narita A; Sakaguchi H; Sakaguchi K; Yoshida N; Nishio N; Hama A; Takahashi Y; Kudo K; Kato K; Kojima S
    J Clin Oncol; 2016 Oct; 34(28):3451-9. PubMed ID: 27507882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
    Gu Z; Churchman M; Roberts K; Li Y; Liu Y; Harvey RC; McCastlain K; Reshmi SC; Payne-Turner D; Iacobucci I; Shao Y; Chen IM; Valentine M; Pei D; Mungall KL; Mungall AJ; Ma Y; Moore R; Marra M; Stonerock E; Gastier-Foster JM; Devidas M; Dai Y; Wood B; Borowitz M; Larsen EE; Maloney K; Mattano LA; Angiolillo A; Salzer WL; Burke MJ; Gianni F; Spinelli O; Radich JP; Minden MD; Moorman AV; Patel B; Fielding AK; Rowe JM; Luger SM; Bhatia R; Aldoss I; Forman SJ; Kohlschmidt J; Mrózek K; Marcucci G; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Paietta E; Willman CL; Loh ML; Hunger SP; Mullighan CG
    Nat Commun; 2016 Nov; 7():13331. PubMed ID: 27824051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular characteristics of
    Ohki K; Kiyokawa N; Saito Y; Hirabayashi S; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fukushima K; Hasegawa D; Fukushima H; Imai M; Kajiwara R; Koike T; Komori I; Matsui A; Mori M; Moriwaki K; Noguchi Y; Park MJ; Ueda T; Yamamoto S; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Takahashi H; Fukushima T; Hayashi Y; Koh K; Manabe A; Ohara A;
    Haematologica; 2019 Jan; 104(1):128-137. PubMed ID: 30171027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
    Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
    Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel
    Van Outersterp I; Hormann FM; Hoogkamer AQ; Boeree A; Van den Broek SA; Den Boer ML; Boer JM
    Haematologica; 2023 Oct; 108(10):2859-2864. PubMed ID: 37051743
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell lines.
    Akahane K; Yasuda T; Tsuzuki S; Hayakawa F; Kiyokawa N; Somazu S; Watanabe A; Kagami K; Abe M; Harama D; Goi K; Kawazu M; Kojima S; Imamura T; Goto H; Iwamoto S; Minegishi M; Abe M; Hojo H; Inaba T; Mano H; Sugita K; Inukai T
    Hematol Oncol; 2020 Oct; 38(4):614-617. PubMed ID: 32515032
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia.
    Sun J; Yu W; Zhang X
    Ann Hematol; 2020 Jan; 99(1):185-188. PubMed ID: 31781846
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathogenic role of MEF2D-SS18 fusion gene in B-cell acute lymphoblastic leukemia.
    Zhang M; Mao D; Zhang W
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1331-1336. PubMed ID: 29408457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.
    Hirano D; Hayakawa F; Yasuda T; Tange N; Yamamoto H; Kojima Y; Morishita T; Imoto N; Tsuzuki S; Mano H; Naoe T; Kiyoi H
    Oncogene; 2019 Mar; 38(13):2263-2274. PubMed ID: 30478446
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Sadras T; Müschen M
    Blood Cancer Discov; 2020 Jul; 1(1):18-20. PubMed ID: 34661138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
    Pine SR; Wiemels JL; Jayabose S; Sandoval C
    Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
    Deucher AM; Qi Z; Yu J; George TI; Etzell JE
    Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.
    Prima V; Gore L; Caires A; Boomer T; Yoshinari M; Imaizumi M; Varella-Garcia M; Hunger SP
    Leukemia; 2005 May; 19(5):806-13. PubMed ID: 15744350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and molecular measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia patients with MEF2D fusions.
    Sun K; Chen WM; Wang X; Zhao XS; Li LD; Hao Y; Wang J; Xu N; Jiang Q; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Qin YZ
    Hematol Oncol; 2023 Aug; 41(3):594-597. PubMed ID: 36516881
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
    Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
    Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.
    Ohki K; Butler ER; Kiyokawa N; Hirabayashi S; Bergmann AK; Möricke A; Boer JM; Cavé H; Cazzaniga G; Yeoh AEJ; Sanada M; Imamura T; Inaba H; Mullighan CG; Loh ML; Norén-Nyström U; Shih LY; Zaliova M; Pui CH; Haas OA; Harrison CJ; Moorman AV; Manabe A
    Leukemia; 2023 Jan; 37(1):212-216. PubMed ID: 36309560
    [No Abstract]   [Full Text] [Related]  

  • 19. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
    Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C
    Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature B-cell acute lymphoblastic leukemia with t(9;11) translocation: a distinct subset of B-cell acute lymphoblastic leukemia.
    Tsao L; Draoua HY; Osunkwo I; Nandula SV; Murty VV; Mansukhani M; Bhagat G; Alobeid B
    Mod Pathol; 2004 Jul; 17(7):832-9. PubMed ID: 15098014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.